Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;50(12):4186-8.
doi: 10.1128/AAC.00494-06. Epub 2006 Oct 16.

Pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem, in healthy male Caucasian volunteers

Affiliations

Pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem, in healthy male Caucasian volunteers

Takahiro Shibayama et al. Antimicrob Agents Chemother. 2006 Dec.

Abstract

The CS-023 concentration in plasma after administration by infusion to healthy volunteers at a dose of 700 mg was decreased, with a half-life of 1.7 h, and the cumulative urinary excretion was 59.4% of the dose. The total clearance, renal clearance, and volume of distribution were 8.12 liters/h, 4.14 liters/h, and 17.2 liters, respectively.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Chemical structure of CS-023.
FIG. 2.
FIG. 2.
Plasma concentration-time profiles of CS-023 after administration by intravenous infusion for 30 min to healthy male Caucasian volunteers over a dose range of 50 to 2,100 mg. Each point represents the mean ± SD for six volunteers. The plasma concentrations were not detected at 24 h after the start of the infusion in all cases.

Similar articles

Cited by

References

    1. Bax, R. P., W. Bastain, A. Featherstone, D. M. Wilkinson, M. Hutchison, and S. J. Haworth. 1989. The pharmacokinetics of meropenem in volunteers. J. Antimicrob. Chemother. 24(Suppl. A):311-320. - PubMed
    1. Craig, W. A. 1997. The pharmacology of meropenem, a new carbapenem antibiotic. Clin. Infect. Dis. 24(Suppl. 2):S266-S275. - PubMed
    1. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-10. - PubMed
    1. Davies, B., and T. Morris. 1993. Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1093-1095. - PubMed
    1. Drusano, G. L., and H. C. Standiford. 1985. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers. Am. J. Med. 78(Suppl. 6A):47-53. - PubMed

LinkOut - more resources